DOI: 10.1055/s-00000019

Fortschritte der Neurologie · Psychiatrie

References

Calabresi PA, Kieseier BC, Arnold DL et al.
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.

Lancet Neurol 2014;
13: 657-665

Download Bibliographical Data

Search in:
Access: